Literature DB >> 17984769

Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray.

Michael Puderbach1, Monika Eichinger, Julie Haeselbarth, Sebastian Ley, Annette Kopp-Schneider, Siegfried Tuengerthal, Astrid Schmaehl, Christian Fink, Christian Plathow, Matthias Wiebel, Sueha Demirakca, Frank-Michael Müller, Hans-Ulrich Kauczor.   

Abstract

OBJECTIVES: As pulmonary complications are life limiting in patients with cystic fibrosis (CF), repeated chest imaging [chest x-ray, computed tomography (CT)] is needed for follow up. With the continuously rising life expectancy of CF patients, magnetic resonance imaging (MRI) as a radiation-free imaging modality might become more and more attractive. The goal of this study was to prospectively assess the value of MRI for evaluation of morphologic pulmonary CF-changes in comparison to established imaging modalities.
MATERIALS AND METHODS: Thirty-one CF patients (19 female, 12 male; mean age 16.7 years) with stable lung disease were examined by MRI: HASTE, coronal/transversal (TR/TE/alpha/TA: infinite/28 ms/180 degrees /18 s), multi-detector computed tomography (MDCT) (30 patients): 120 kV, dose modulated mAs, and chest x-ray (21 patients). Image evaluation: random order, 4 chest radiologists in consensus; chest x-ray: modified Chrispin-Norman score; CT and MRI: modified Helbich score. The maximal attainable score for chest x-ray was 34, for MRI and CT 25. Median scores, Pearson correlation coefficients, Bland-Altman plots, and concordance of MRI to CT on a lobar and segmental basis were calculated.
RESULTS: The median MRI and MDCT scores were 13 (min 3, max 20) respectively 13.5 (min 0, max 20). The median chest x-ray score was 14 (min 5, max 32). Pearson correlation coefficients: MRI/CT = 0.80, P < 0.0001; MRI/chest x-ray = 0.63, P < 0.0018; chest x-ray/CT = 0.75, P < 0.0001. The median lobe related concordance was 80% for bronchiectasis, 77% for mucus plugging, 93%, for sacculation/abscesses, and 100% for collapse/consolidation.
CONCLUSIONS: Morphologic MRI of the lung in CF patients demonstrates comparable results to MDCT and chest x-ray. Because radiation exposure is an issue in CF patients, MRI might have the ability to be used as an appropriate alternative method for pulmonary imaging.

Entities:  

Mesh:

Year:  2007        PMID: 17984769     DOI: 10.1097/RLI.0b013e318074fd81

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  34 in total

Review 1.  Emphysema and lung volume reduction: the role of radiology.

Authors:  Katharina Martini; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  MRI of respiratory dynamics with 2D steady-state free-precession and 2D gradient echo sequences at 1.5 and 3 Tesla: an observer preference study.

Authors:  M Fabel; B J Wintersperger; O Dietrich; M Eichinger; C Fink; M Puderbach; H-U Kauczor; S O Schoenberg; J Biederer
Journal:  Eur Radiol       Date:  2008-09-06       Impact factor: 5.315

3.  Imaging of molecular signatures of specific structures, functions,and pathological alterations in the lung tissue.Chair's Summary.

Authors:  Vladimir R Muzykantov
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

Review 4.  Can lung MR replace lung CT?

Authors:  Michael Puderbach; Hans-Ulrich Kauczor
Journal:  Pediatr Radiol       Date:  2008-06

Review 5.  Ten years of chest MRI for patients with cystic fibrosis : Translation from the bench to clinical routine.

Authors:  Patricia Leutz-Schmidt; Monika Eichinger; Mirjam Stahl; Olaf Sommerburg; Jürgen Biederer; Hans-Ulrich Kauczor; Michael U Puderbach; Marcus A Mall; Mark O Wielpütz
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

Review 6.  Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Jessica E Pittman; Garry Cutting; Stephanie D Davis; Thomas Ferkol; Richard Boucher
Journal:  Ann Am Thorac Soc       Date:  2014-04

7.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

Review 8.  The role of advanced imaging techniques in cystic fibrosis follow-up: is there a place for MRI?

Authors:  Michael Puderbach; Monika Eichinger
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 9.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

10.  Lung disease assessment in primary ciliary dyskinesia: a comparison between chest high-field magnetic resonance imaging and high-resolution computed tomography findings.

Authors:  Silvia Montella; Francesca Santamaria; Marco Salvatore; Marco Maglione; Paola Iacotucci; Maria Margherita De Santi; Carmine Mollica
Journal:  Ital J Pediatr       Date:  2009-08-06       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.